Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revelation Biosciences, Inc. - Common Stock (NQ:REVB)

0.8800 +0.0098 (+1.13%)
Streaming Delayed Price Updated: 10:41 AM EDT, Sep 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,502
Open 0.8800
Bid (Size) 0.8651 (500)
Ask (Size) 0.8999 (500)
Prev. Close 0.8702
Today's Range 0.8800 - 0.8800
52wk Range 0.8502 - 6.760
Shares Outstanding 6,297,303
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
From Revelation Biosciences, Inc.
Via Business Wire
Revelation Biosciences (NASDAQ:REVB) Surges on Pipeline Progress Despite Q2 Earnings Miss ↗
Via Chartmill

Performance

YTD
-72.9%
-72.9%
1 Month
-16.2%
-16.2%
3 Month
-15.4%
-15.4%
6 Month
-26.1%
-26.1%
1 Year
-84.6%
-84.6%

More News

Read More
News headline image
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Independent Market Assessment Results Show $94 Billion Total Addressable Market for Gemini in Stage 2 and Stage 3 Acute Kidney Injury
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Announces Adoption of Stockholder Rights Plan
From Revelation Biosciences, Inc.
Via ACCESS Newswire
News headline image
Revelation Biosciences Expands Acute Kidney Injury Advisory Board
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Releases Corporate Update Letter to Stockholders
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026
Via ACCESS Newswire
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
Revelation Biosciences Announces Formation of Acute Kidney Injury Advisory Board
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Via ACCESS Newswire
News headline image
REMINDER: Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
Via ACCESS Newswire
News headline image
Revelation Biosciences to Host Fireside Chat at 38th Annual Roth Conference
Via ACCESS Newswire
News headline image
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
News headline image
REVB Stock Drops 10% After Company Announces Third Reverse Split In A Year ↗
Via Stocktwits
News headline image
American Lithium Minerals (OTC: AMLM) Accelerates Global Expansion Across Gold, Silver, Copper, Critical Minerals, and Rare Earth Elements
Via AB Newswire
What's going on in today's session ↗
Via Chartmill
In today's session, these stocks are experiencing unusual volume. ↗
Via Chartmill
Which stocks are moving on Friday? ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
Thursday's session: top gainers and losers ↗
Via Chartmill
News headline image
Revelation Biosciences Reaches Agreement with FDA on Gemini Approval Pathway for AKI
Via ACCESS Newswire
News headline image
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026)
Via ACCESS Newswire

Frequently Asked Questions

Is Revelation Biosciences, Inc. - Common Stock publicly traded?
Yes, Revelation Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Revelation Biosciences, Inc. - Common Stock trade on?
Revelation Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Revelation Biosciences, Inc. - Common Stock?
The ticker symbol for Revelation Biosciences, Inc. - Common Stock is REVB on the Nasdaq Stock Market
What is the current price of Revelation Biosciences, Inc. - Common Stock?
The current price of Revelation Biosciences, Inc. - Common Stock is 0.8800
When was Revelation Biosciences, Inc. - Common Stock last traded?
The last trade of Revelation Biosciences, Inc. - Common Stock was at 09/28/26 10:41 AM ET
What is the market capitalization of Revelation Biosciences, Inc. - Common Stock?
The market capitalization of Revelation Biosciences, Inc. - Common Stock is 5.54M
How many shares of Revelation Biosciences, Inc. - Common Stock are outstanding?
Revelation Biosciences, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.